Optimind Pharma (XCNQ:OMND) FCF Margin % : -25.93% (As of Nov. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Optimind Pharma FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Optimind Pharma's Free Cash Flow for the three months ended in Nov. 2023 was C$-0.01 Mil. Optimind Pharma's Revenue for the three months ended in Nov. 2023 was C$0.03 Mil. Therefore, Optimind Pharma's FCF Margin % for the quarter that ended in Nov. 2023 was -25.93%.

As of today, Optimind Pharma's current FCF Yield % is -127.76%.

The historical rank and industry rank for Optimind Pharma's FCF Margin % or its related term are showing as below:

XCNQ:OMND' s FCF Margin % Range Over the Past 10 Years
Min: -612.35 Med: -612.35 Max: -453.62
Current: -453.62

During the past 2 years, the highest FCF Margin % of Optimind Pharma was -453.62%. The lowest was -612.35%. And the median was -612.35%.

XCNQ:OMND's FCF Margin % is ranked worse than
94.35% of 1027 companies
in the Drug Manufacturers industry
Industry Median: -0.55 vs XCNQ:OMND: -453.62

Optimind Pharma FCF Margin % Historical Data

The historical data trend for Optimind Pharma's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Optimind Pharma FCF Margin % Chart

Optimind Pharma Annual Data

Trend

Feb22

Feb23

FCF Margin %

-612.35

Optimind Pharma Quarterly Data
	Jun21	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23
FCF Margin %	Get a 7-Day Free Trial			-513.33	-369.77	-595.12	-800.00	-25.93

Competitive Comparison of Optimind Pharma's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Optimind Pharma's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Optimind Pharma's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Optimind Pharma's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Optimind Pharma's FCF Margin % falls into.

Optimind Pharma FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Optimind Pharma's FCF Margin for the fiscal year that ended in Feb. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Feb. 2023 )	/	Revenue (A: Feb. 2023 )
	=	-1.041	/	0.17
	=	-612.35 %

Optimind Pharma's FCF Margin for the quarter that ended in Nov. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Nov. 2023 )	/	Revenue (Q: Nov. 2023 )
	=	-0.007	/	0.027
	=	-25.93 %

Optimind Pharma FCF Margin % Related Terms

Thank you for viewing the detailed overview of Optimind Pharma's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Optimind Pharma (XCNQ:OMND) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Optimind Pharma Corp (XCNQ:OMND) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

3000 - 77 King Street West, TD Centre, North Tower, PO Box 95, Toronto, ON, CAN, M5K 1G8

Website

https://www.optimindpharma.com

Optimind Pharma Corp is an emerging provider of psychedelic therapies for the masses. It helps people suffering from PTSD, Anxiety, Depression, and other mental illnesses and disabilities by providing ketamine-assisted-treatment and other psychedelic-enhanced-psychotherapy modalities.

Optimind Pharma (XCNQ:OMND) Headlines

No Headlines